Cargando…
Predictive and Prognostic Protein Biomarkers in Epithelial Ovarian Cancer: Recommendation for Future Studies
Epithelial ovarian cancer is the most lethal gynecological malignancy. Due to its lack of symptoms, this disease is diagnosed at an advanced stage when the cancer has already spread to secondary sites. While initial rates of response to first treatment is >80%, the overall survival rate of patien...
Autores principales: | Le Page, Cécile, Huntsman, David G., Provencher, Diane M., Mes-Masson, Anne-Marie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835111/ https://www.ncbi.nlm.nih.gov/pubmed/24281100 http://dx.doi.org/10.3390/cancers2020913 |
Ejemplares similares
-
A COEUR cohort study of SATB2 expression and its prognostic value in ovarian endometrioid carcinoma
por: Le Page, Cécile, et al.
Publicado: (2019) -
RAN Nucleo-Cytoplasmic Transport and Mitotic Spindle Assembly Partners XPO7 and TPX2 Are New Prognostic Biomarkers in Serous Epithelial Ovarian Cancer
por: Cáceres-Gorriti, Katia Y., et al.
Publicado: (2014) -
An essential role for Ran GTPase in epithelial ovarian cancer cell survival
por: Barrès, Véronique, et al.
Publicado: (2010) -
BMP-2 signaling in ovarian cancer and its association with poor prognosis
por: Le Page, Cécile, et al.
Publicado: (2009) -
BTN3A2 Expression in Epithelial Ovarian Cancer Is Associated with Higher Tumor Infiltrating T Cells and a Better Prognosis
por: Le Page, Cécile, et al.
Publicado: (2012)